Proactive Investors - Run By Investors For Investors

Sphere Medical pushing forward with Johnson & Johnson partnership

Stuart Hendry, CEO of Sphere Medical (LON:SPHR), tells Proactiveinvestors that the company is anticipating a major milestone with the CE Mark for blood analyser Proxima. Using this, the new partnership with OCD, a unit of the medical devices company Johnson & Johnson, Sphere will then commercialise the platform globally.
Meet Alliance Pharma PLC, IXICO PLC, Benchmark Holdings PLC, Clinigen Group PLC and Shield Therapeutics PLC at our event, London , 24 January 2019. Register here »
View full SPHR profile View Profile

Sphere Medical Holding PLC Timeline

© Proactive Investors 2019

Proactive Investors Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use